Skip to main
MYGN
MYGN logo

Myriad Genetics (MYGN) Market Capitalization Overview

Market Cap: $463.66M as of Jun 13, 2025

$463.66M
Past Month+$84.81M (22.38%)
As of Jun 13, 2025, Myriad Genetics (MYGN) has a market capitalization of $463.66M. Over the past 30 days, its market cap has decreased by -37.44%, while in the last 12 months, it has decreased by -62.85%.

Market capitalization represents the total value of Myriad Genetics as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.

Myriad Genetics (MYGN) Market Cap Formula = Stock Price * Shares Outstanding

The market cap of Myriad Genetics (MYGN) helps investors assess the company's size and compare it with competitors for better investment decisions.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

Myriad Genetics (MYGN) Market Cap History

DateMarket CapChange
Jun 2, 2025$411.12M-37.44%
May 1, 2025$657.19M-18.58%
Apr 1, 2025$807.18M-14.66%
Mar 3, 2025$945.86M-18.64%
Feb 3, 2025$1.17B-5.41%
Jan 2, 2025$1.23B-19.11%

Myriad Genetics (MYGN) End of Year Market Cap History

DateMarket CapChange
2025$463.66M-62.85%
2024$1.25B-20.67%
2023$1.58B+33.80%
2022$1.18B-46.65%
2021$2.21B+48.19%
2020$1.49B

FAQs About Myriad Genetics (MYGN) Market Cap

As of Jun 13, 2025, the market capitalization of Myriad Genetics (MYGN) is $463.66M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.

In the last 30 days, Myriad Genetics’s market capitalization has increased by 22.38%, changing from $378.85M to $463.66M as of Jun 13, 2025.

In the last 3 months, Myriad Genetics’s market capitalization has increased by —, changing from – to – as of –.

In the year 2024, Myriad Genetics’s market capitalization decreased from $1.58B in January to $1.25B in December, reflecting a -20.67% change.

In the past five years, Myriad Genetics (MYGN) has had a compound annual growth rate (CAGR) of -3.45% in market capitalization. This means its market cap has shrunk at an average rate of -3.45% per year.

Myriad Genetics (MYGN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.